Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
We try to be the best navigators possible, conserving fuel for the full journey. But we don’t control the length of the detour; cancer does.
I never met Jim beyond liking or commenting on each other’s posts, but the news hit me harder than I expected.
Conservative management is now the most common choice for men with low-risk prostate cancer.
Darolutamide delays metastasis and reduces the risk of death in men with high-risk prostate cancer.
These men lived for a median of 30 months compared to 26 months for white men.
Facing any illness in general or cancer in particular as a single person poses its own set of unique challenges.
But, despite the difference, the risk of dying from the disease is still small.
Local hospitals can use partnerships to offer greater access to specialists and treatment—though famous names don’t guarantee quality care...
I’m still here and still blogging (a reason to celebrate) — but now about recurrent cancer. #CancerSucks
But new vaccines hold promise for prevention.
The risk is highest following pancreatic and lung cancer diagnoses.
New UCSF study analyzes prostate cancer deaths by race.
Cancer mortality declined by 27 percent over the past 25 years.
What’s actually been gnawing at me since my last post like this six months ago is something completely different—relationships.
The benefits? Risk is assessed more rapidly and at a cheaper cost.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.